Mankind Pharma Ltd
Ticker: MANKIND
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
2445.70
Market Cap
100948.34
Debt/Equity
0.5842
ROE %
16.492
PB
6.9294
Promoter %
72.672
Pledge %
0.000
1Y Rev Growth %
20.879
5Y Rev Growth %
16.341
NP Margin %
15.602
NP Margin 5Y Avg %
17.172
Trading Reference
1M Return %
-4.947
6M Return %
0.808
1Y Return %
-10.978
% Away 52W High
24.905
% Away 52W Low
15.630
Daily Volume
503217
Investment Verdict
Hold
Score 66/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 24/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Mankind Pharma Ltd is currently trading near its support level, with the 50-day EMA indicating a potential upward trend if it breaks resistance at the recent highs. Volume has been increasing, suggesting strong buying interest. Therefore, there is a favorable outlook for a price increase in the medium term.
Upside Probability: 15% | Downside Probability: 8%
Probability estimates are technical-context statements, not investment advice.
More Options
H
Hero MotoCorp Ltd
Hero MotoCorp has a decent standing in the market, but faces challenges in growth consistency and valuation metrics. The transition to electric vehicles and competition will be critical for future performance.
View details
J
Jindal Steel Ltd
Jindal Steel Ltd shows decent potential with consistent growth, but faces challenges in profitability and valuation metrics.
View details
Z
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd shows potential for growth, but faces challenges in profitability and market competition.
View details
W
Waaree Energies Ltd
Waaree Energies Ltd shows potential in the renewable energy sector, but faces challenges in profitability and execution risks.
View details
U
Union Bank of India Ltd
Union Bank of India shows moderate potential with some growth prospects, but faces challenges in profitability and execution risks.
View details
C
Canara Bank Ltd
Canara Bank shows potential for moderate growth but faces challenges in profitability and execution risks.
View details
I
IDBI Bank Ltd
IDBI Bank Ltd presents a risky investment opportunity with moderate growth and profitability concerns.
View details
A
Adani Energy Solutions Ltd
Adani Energy Solutions Ltd shows potential in a growing sector, but faces significant challenges that could impact its performance.
View details
H
Havells India Ltd
Havells India Ltd shows a decent investment opportunity with strong growth potential, but investors should be cautious of valuation and execution risks.
View details
R
REC Limited
REC Limited shows potential for growth in a vital sector, but investors should be cautious of execution risks and governance issues.
View details
S
Swiggy Ltd
Swiggy Ltd shows potential for growth but faces significant challenges in profitability and competition. Caution is advised.
View details
D
Dabur India Ltd
Dabur India Ltd shows decent fundamentals with consistent growth and a strong balance sheet, but valuation concerns and execution risks need to be monitored.
View details
I
Indus Towers Ltd
Indus Towers Ltd shows potential in a growing sector but faces challenges in execution and market competition.
View details
M
Marico Ltd
Marico Ltd shows a decent investment opportunity with stable growth and profitability metrics, though some risks remain.
View details
U
United Spirits Ltd
United Spirits Ltd shows potential for growth, but faces challenges in profitability and valuation metrics.
View details
I
ICICI Lombard General Insurance Company Ltd
ICICI Lombard shows potential but faces challenges in profitability and competitive pressures.
View details
Business Overview
Mankind Pharma Ltd is a leading Indian pharmaceutical company dedicated to improving healthcare through innovative and affordable medicines. Established in 1991, it focuses on a diverse range of therapeutic areas, catering to the needs of millions across India. With a strong commitment to quality and accessibility, Mankind Pharma is a trusted partner for healthcare professionals and patients alike. Its robust product portfolio and strategic partnerships position it as a key player in the Indian pharmaceutical landscape.
- Established leader in the Indian pharmaceutical sector
- Wide range of therapeutic products
- Focus on affordability and accessibility
- Strong commitment to quality and innovation
- Trusted by healthcare professionals and patients
- Strategic growth through partnerships and expansion
Investment Thesis
Mankind Pharma Ltd stands out with a strong promoter group that enhances credibility in the market. The company's focus on digital services presents a significant growth opportunity. Additionally, its attractive valuation compared to peers makes it a compelling investment choice for retail investors seeking long-term gains.
- Strong promoter group ensures credibility and trust.
- Significant growth potential in digital services sector.
- Attractive valuation compared to industry peers.
- Robust product pipeline supports sustained revenue growth.
- Strategic expansion plans enhance market presence.
Opportunity vs Risk
Opportunities
- Strong growth in pharmaceutical sector
- Expanding product portfolio
- Rising healthcare awareness in India
- Potential for export growth
Risks ⚠️
- Regulatory challenges in pharma industry
- Intense competition from generic drugs
- Dependency on key products
- Market volatility affecting stock price
Peer Perspective
Mankind Pharma Ltd trades at a slight premium compared to peers like Sun Pharmaceutical and Cipla, reflecting its robust growth trajectory. For a rerating, sustained margin stability is essential to enhance investor confidence.
Future Outlook
Mankind Pharma Ltd has strong growth potential driven by its expanding product portfolio and market presence; however, successful execution and effective cost control will be crucial to fully realize this potential in the coming years.
AI FAQs for Retail Users
- Q: What does Mankind Pharma Ltd do?A: Mankind Pharma Ltd is a pharmaceutical company that develops, manufactures, and markets a range of healthcare products.
- Q: Is Mankind Pharma Ltd publicly listed?A: Yes, Mankind Pharma Ltd is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) in India.
- Q: What are the key products of Mankind Pharma Ltd?A: Mankind Pharma offers a variety of products including prescription medicines, over-the-counter drugs, and consumer healthcare items.
- Q: How can I invest in Mankind Pharma Ltd?A: You can invest by purchasing shares through a registered stockbroker or online trading platform.
- Q: What factors can affect Mankind Pharma's stock price?A: Stock price may be influenced by company performance, market conditions, regulatory changes, and overall economic factors.
📊 Stock Investment Checklist (100 Points)
Mankind Pharma Ltd • Updated: 2025-09-17 15:54:17
-
10BusinessHighPharmaceutical sector is essential and growing, but competition is intense.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighP/E ratio is higher than peers, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Mankind Pharma Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 60/100
- Market Confidence: 68/100